Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01532713
Other study ID # 4-2011-0358
Secondary ID
Status Completed
Phase N/A
First received February 8, 2012
Last updated March 4, 2014
Start date January 2012
Est. completion date March 2013

Study information

Verified date March 2014
Source Yonsei University
Contact n/a
Is FDA regulated No
Health authority Korea: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

Stellate ganglion block (SGB) is known to increase blood flow to the innervation area of the stellate ganglion. Near infrared spectroscopy reflects changes of blood volume and allows continuous, non-invasive, and bedside monitoring of regional cerebral oxygen saturation (rSO2). Previous studies have shown the increment of the rSO2 on the block side from the baseline and the decrement of the rSO2 on the non-block side after SGB. Patients with cerebral vascular disease undergoing SGB might be at risk a decrease in cerebral blood flow in the non-block side. The investigators researched the effect of oxygen administration on rSO2 in the non-block side using a near infrared spectroscopy after SGB. 5 L/min oxygen was supplied via nasal cannula from 15 minutes after SGB. The rSO2 in the non-block side were measured before SGB and 5, 10, 15, 20, 25 and 30 minutes after SGB.

The present study suggests that oxygen administration can increase the rSO2 of non-block side. In conclusion, it is our belief that oxygen supplement is helpful to the patient with cerebral vascular disease during SGB.


Recruitment information / eligibility

Status Completed
Enrollment 38
Est. completion date March 2013
Est. primary completion date December 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 20 Years to 70 Years
Eligibility Inclusion Criteria:

- ages between 20 and 70 years

- ASA PS 1,2

- disease entity : pain in the head, neck, upper extremity, and SSNHL ( sudden sensory neural hearing loss )

Exclusion Criteria:

- patient with the tendency to bleed

- patient who had cerebrovascular disease

- patient with respiratory disease ( COPD: chronic obstructive lung disease )

- patients who do not give written informed consent to participate in the study

Study Design

Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Procedure:
oxygen administration
nasal O2 5L/min via nasal cannula

Locations

Country Name City State
Korea, Republic of Severance Hospital Seoul

Sponsors (1)

Lead Sponsor Collaborator
Yonsei University

Country where clinical trial is conducted

Korea, Republic of, 

References & Publications (1)

Park HM, Kim TW, Choi HG, Yoon KB, Yoon DM. The change in regional cerebral oxygen saturation after stellate ganglion block. Korean J Pain. 2010 Jun;23(2):142-6. doi: 10.3344/kjp.2010.23.2.142. Epub 2010 May 31. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary increase on the regional cerebral oxygen saturation The rSO2 on the non-block side after SGB and additional oxygen administration will be compared with the baseline rSO2. 5 minutes after oxygen administration No